Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$3.17 - $7.91 $118,519 - $295,739
-37,388 Reduced 58.66%
26,351 $90,000
Q2 2023

Aug 10, 2023

SELL
$7.35 - $13.21 $26,731 - $48,044
-3,637 Reduced 5.4%
63,739 $469,000
Q1 2023

May 12, 2023

SELL
$7.79 - $16.29 $86,944 - $181,812
-11,161 Reduced 14.21%
67,376 $698,000
Q4 2022

Feb 10, 2023

BUY
$11.0 - $21.45 $253,990 - $495,280
23,090 Added 41.64%
78,537 $929,000
Q3 2022

Nov 01, 2022

BUY
$20.09 - $35.8 $1.11 Million - $1.99 Million
55,447 New
55,447 $1.16 Million
Q2 2022

Aug 09, 2022

BUY
$27.42 - $43.63 $87,798 - $139,703
3,202 Added 7.77%
44,431 $1.38 Million
Q1 2022

May 12, 2022

SELL
$36.48 - $52.22 $10,506 - $15,039
-288 Reduced 0.69%
41,229 $1.74 Million
Q4 2021

Feb 14, 2022

BUY
$33.11 - $55.01 $622,898 - $1.03 Million
18,813 Added 82.86%
41,517 $1.8 Million
Q3 2021

Nov 15, 2021

BUY
$50.07 - $66.05 $238,333 - $314,398
4,760 Added 26.53%
22,704 $1.15 Million
Q2 2021

Aug 11, 2021

BUY
$56.61 - $80.46 $32,720 - $46,505
578 Added 3.33%
17,944 $1.13 Million
Q1 2021

May 17, 2021

SELL
$86.23 - $125.19 $151,419 - $219,833
-1,756 Reduced 9.18%
17,366 $1.61 Million
Q4 2020

Feb 16, 2021

SELL
$79.17 - $111.47 $186,207 - $262,177
-2,352 Reduced 10.95%
19,122 $1.71 Million
Q3 2020

Nov 17, 2020

SELL
$81.91 - $134.94 $2.22 Million - $3.65 Million
-27,042 Reduced 55.74%
21,474 $2.22 Million
Q3 2020

Nov 13, 2020

SELL
$81.91 - $134.94 $504,647 - $831,365
-6,161 Reduced 11.27%
48,516 $5.01 Million
Q2 2020

Aug 17, 2020

SELL
$54.33 - $89.52 $157,285 - $259,160
-2,895 Reduced 5.03%
54,677 $4.33 Million
Q1 2020

May 14, 2020

BUY
$49.34 - $68.76 $168,989 - $235,503
3,425 Added 6.33%
57,572 $3.33 Million
Q4 2019

Feb 11, 2020

BUY
$51.21 - $59.06 $2.77 Million - $3.2 Million
54,147 New
54,147 $2.92 Million
Q3 2019

Oct 25, 2019

SELL
$40.6 - $57.2 $2.45 Million - $3.45 Million
-60,369 Closed
0 $0
Q2 2019

Jul 31, 2019

SELL
$39.92 - $53.86 $24,510 - $33,070
-614 Reduced 1.01%
60,369 $0
Q1 2019

May 08, 2019

BUY
$48.23 - $66.16 $83,630 - $114,721
1,734 Added 2.93%
60,983 $3.08 Million
Q4 2018

Feb 12, 2019

BUY
$55.63 - $73.24 $381,343 - $502,060
6,855 Added 13.08%
59,249 $3.24 Million
Q3 2018

Nov 13, 2018

BUY
$52.05 - $66.51 $333,796 - $426,528
6,413 Added 13.95%
52,394 $3.45 Million
Q1 2018

May 10, 2018

SELL
$44.44 - $54.39 $13,287 - $16,262
-299 Reduced 0.65%
45,981 $2.42 Million
Q4 2017

Feb 09, 2018

SELL
$37.77 - $47.75 $44,870 - $56,727
-1,188 Reduced 2.5%
46,280 $2.15 Million
Q3 2017

Nov 09, 2017

BUY
$34.14 - $40.45 $1.62 Million - $1.92 Million
47,468
47,468 $1.89 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.